Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 

Show More News:
 Watch more news

News search related to the stock Pfizer (ordered by date):

  1. Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study  Pfizer
  2. Pfizer says its antiviral pill slashes risk of severe COVID-19 by 89%  Reuters
  3. Pfizer strikes deal to allow generic versions of its Covid pill for world?s poor  The Guardian
  4. Historic pharma precedent: Pfizer agrees to share its Covid-19 pill secrets with dozens of companies around the world  City A.M.
  5. Pfizer seeks FDA authorisation for Covid-19 pill  Financial Times
  1. Pfizer Expects Covid Vaccine to Be Effective Against Omicron  Bloomberg
  2. Pfizer working on updated jab in response to Omicron, to be ready in 100 days  Livemint
  3. Pfizer research head sees a sprint to develop Omicron vaccine, if needed  STAT
  4. Pfizer CEO confident Covid treatment pill will be effective against omicron variant  CNBC
  5. Pfizer working on updated jab in response to Omicron variant: CEO  Business Standard
Annual Covid-19 jabs are likely, says Pfizer boss  The Independent Pfizer or Moderna: Which COVID Vaccine Is Better?  WebMD The inside story of the Pfizer vaccine: 'a once-in-an-epoch windfall'  Financial Times 3 Reasons Pfizer Stock Will Crush the Broader Market in 2022  Motley Fool AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing  Pfizer Six Vaccines Show Promise as Boosters, Led by Pfizer and Moderna  Bloomberg GSK poaches key vaccine executive from Pfizer  Financial Times 3 Hard Facts Moderna and Pfizer Investors Need to Know About the Omicron Variant  Motley Fool Omicron: scientist behind Pfizer jab urges public not to ?freak out? over variant  Evening Standard How to choose the right booster shot for COVID-19: Pfizer or Moderna  Business Insider Pfizer Vaccine Wins Approval in Italy for Kids Aged 5-11  Bloomberg Pfizer Asks F.D.A. to Authorize Boosters for 16- and 17-Year-Olds  The New York Times South Africa in Talks With Pfizer, Merck for Covid Pills  Bloomberg Investing in Pfizer Stock (PFE)  Investopedia 70 young children given expired Pfizer vaccine doses in Prince George's County  WJLA Will Pfizer Stock Continue To Rise?  Forbes Pfizer's One-Two-Punch Against COVID  Seeking Alpha Covid: Coroner probes death of New Zealand tradie Rory James Nairn 12 days after Pfizer vaccine jab  Daily Mail Pfizer Stock May Break Out On New COVID Variant  Seeking Alpha Why Novavax and Pfizer Are Trouncing the Market Today  Motley Fool Pfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine  FiercePharma Pfizer CEO on Omicron Covid-19 Variant, Vaccine Supply  Bloomberg Covid: Germany to ban unvaccinated people from shops and bars  BBC News Pfizer Inc. stock falls Thursday, underperforms market  MarketWatch Exact Sciences Breaks Up With Pfizer -- Time to Buy?  Motley Fool Pfizer Is Lobbying to Thwart Whistleblowers Exposing Fraud  The Intercept Pfizer Expects Its Jab to Hold Up in Tests Vs. Omicron  Bloomberg Covid-19: New research reveals Pfizer is making misleading claims about fair distribution of vaccines  Amnesty International S. Africa Wants J&J, Pfizer Vaccine Delivery Delay, News24 Says  Bloomberg Is It Too Late to Buy Pfizer Stock?  Motley Fool Pfizer Covid Vaccine Generated Most Antibodies in Comparative Study  Bloomberg Omicron: Pfizer, BioNTech and Moderna race to tweak Covid vaccines against new Coronavirus variant  City A.M. Vietnamese province suspends use of a Pfizer vaccine batch  New Straits Times Online Pfizer and Ogilvy Launch In-Game Covid-19 Vaccinations  Muse by Clio Fact check: New ingredient in Pfizer COVID-19 vaccine mischaracterized in online posts  USA TODAY PH takes delivery of 1 million more Pfizer COVID-19 vaccine doses  INQUIRER.net Pfizer Covid vaccine works against Omicron, Israel claims  NEWS.com.au Pfizer Shows Its R&D Is Strong. That Makes Its Stock a Good Long-Term Bet.  Barron's Omicron variant: Doctor's three Omicron symptoms despite having three doses of Pfizer  Daily Express Should Pfizer Investors Expect a Big Dividend Hike in 2022?  Motley Fool S.Korea to purchase 70000 courses of new Pfizer COVID-19 pill  Reuters The risks of omicron: How Pfizer and Moderna plan to mitigate fears over variant of concern  CityNews Toronto Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana  Pfizer Germany recommends only Biontech/Pfizer vaccine for under-30s  Reuters COVID-19: New oral antiviral from Pfizer looks hopeful  Medical News Today Pfizer Vaccine Supplies Dwindle in Germany  The New York Times U.S. donates nearly 200000 additional Pfizer-BioNTech vaccines to Sri Lanka  US Embassy in Sri Lanka Pfizer board member Gottlieb says the Covid pandemic could be over in the U.S. by January  CNBC Stocks making the biggest moves premarket: Pfizer, Canada Goose, Live Nation and more  CNBC Covid-19 Pandemic, Omicron Variant: Live Updates and News for Dec. 2, 2021  Bloomberg The FDA authorizes Pfizer's COVID-19 vaccine for children ages 5 to 11 ? a pediatrician explains how the drug was tested for safety and efficacy  The Conversation US Covid Updates: Pfizer Says Its Antiviral Pill Is Highly Effective  The New York Times Covid News: Los Angeles Businesses Grapple With Vaccine Mandate  The New York Times Covid News: D.C. Eases Indoor Mask Restrictions  The New York Times Pfizer Stock Active After CFO Retirement, FDA Application For COVID Pill Approval  TheStreet Roche Pulls Plug On Atea's Covid Pill After Pfizer Lobs It To FDA  Investor's Business Daily Australian Open Will Require Players to Be Fully Vaccinated  The New York Times Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age | NEJM  nejm.org Did Dr. Chai Koh Meow Die From Pfizer Booster Dose?  Tech ARP Melbourne mechanic suffers stroke two days after Pfizer vaccine, doctors say ?cause unknown?  NEWS.com.au Kids ages 5-11 and the COVID vaccine: Answers to parents' common questions : Shots - Health News  NPR Taiwan halts 2nd-dose BioNTech vaccinations for ages 12-17 amid concerns of myocarditis  Taiwan News Here?s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month  Forbes FDA authorizes booster dose of Pfizer's Covid-19 vaccine for people 65 and older  CNN Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years  Pfizer Pfizer accused of holding Brazil ?to ransom? over vaccine contract demands  The Guardian Pfizer-BioNTech COVID-19 Vaccine COMIRNATYŽ Receives Full US FDA Approval for Individuals 16 Years and Older  Pfizer Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study  Pfizer Freedom of Information request on REG 174 for Pfizer COVID-19 mRNA vaccine (FOI 21-611)  GOV.UK Pfizer plans to file for full FDA approval of Covid vaccine at the end of this month  CNBC Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs  The Guardian Pfizer and BioNTech Announce Submission of Initial Data to US FDA to Support Booster Dose of COVID-19 Vaccine  Pfizer Pfizer Declares Fourth-Quarter 2021 Dividend  Pfizer Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech  GOV.UK Pfizer and BioNTech Expand Collaboration with US to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries  Pfizer Covid-19: Pfizer vaccine's efficacy declined from 96% to 84% four months after second dose, company reports  The BMJ First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose  GOV.UK Pfizer Covid jab ?90% effective against hospitalisation for at least 6 months?  The Guardian Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared  Pfizer Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults  Pfizer Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech  GOV.UK FactCheck: what are the safety risks of the Pfizer vaccine?  Channel 4 News Pfizer/BioNTech COVID-19 vaccine shelf-life extended from 5 to 31 days, says MHRA  GOV.UK Pfizer raises sales forecast for Covid vaccine by almost a third to $33bn  Financial Times Australia shores up Pfizer supply after days of uncertainty  The Guardian Pfizer Submits Favorable Initial Data To The FDA On Kids' COVID-19 Vaccine Trial  NPR Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study  Pfizer UK signs deal with Pfizer/BioNTech for 35 million vaccines  GOV.UK Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the US FDA  Pfizer Pfizer to Acquire Trillium Therapeutics Inc.  Pfizer Pfizer CEO says third Covid vaccine dose likely needed within 12 months  CNBC Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month  Nasdaq Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for US FDA Approval of Their COVID 19 Vaccine  Pfizer Is Pfizer Stock Set To See Higher Levels Post Q2 Results?  Forbes COVID-19 treatment pill administered in new Pfizer clinical trial  Sky News Pfizer modernises drug development project management with Pega  Diginomica Boys more at risk from Pfizer jab side-effect than Covid, suggests study  The Guardian Pfizer (PFE) Shot's Protection Against Hospitalization Wanes in Study  Bloomberg
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources